-
program at the interface of drug delivery, biomaterials, and cancer biology. The successful candidate will play a key role in developing next-generation therapeutic platforms, including lipid nanoparticles
-
heart regeneration. Your profile PhD and a strong publication record in vascular biology & bioengineering, computational biology, or cardiac/developmental biology and disease modeling. Extensive molecular
-
. At the heart of our program is the GLICO (Glioma-in-a-Cerebral-Organoid)platform, a system we pioneered where patient-derived glioma stem cells are grown within human cerebral organoids. This high-fidelity model
-
(Thorlabs) for imaging large cortical and subcortical areas in awake head-fixed animals, two 2-photon microscopes for single-cell electrophysiological experiments in brain slices (Chun et al, Science 2014
-
exploratory, collaborative, and friendly spirits. Qualifications PhD degree (awarded or expected soon) in Cell biology, Molecular biology, Cancer biology and Immunology is strongly preferred; candidates with
-
or equivalent in Bioinformatics, Molecular Biology, Biochemistry, Computer Science, or related field Special Skills, Knowledge, and Abilities: Required: Candidates must hold a doctoral degree (PhD, MD
-
their Ph.D. in a related field (e.g. Bioengineering and other Engineering fields, Biology, Physics, Chemistry) and have no more than two years' post PhD experience prior to the anticipated start date
-
the fields of cancer survivorship, genetics, stem cell pharmacogenomics, epidemiology, biostatistics, and computational biology. The successful applicant will gain extensive training and experience in genetic
-
research efforts. PREFERRED QUALIFICATIONS: A strong background in murine work, high throughput methods, RNA biology, and/or computational biology are highly desirable. Excellent verbal and written